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Stress response pathways allow cells to sense and respond to environmental changes and adverse pathophysiological
states. Pharmacological modulation of cellular stress pathways has implications in the treatment of human diseases,
including neurodegenerative disorders, cardiovascular disease, and cancer. The quinone methide triterpene celastrol,
derived from a traditional Chinese medicinal herb, has numerous pharmacological properties, and it is a potent activator
of the mammalian heat shock transcription factor HSF1. However, its mode of action and spectrum of cellular targets are
poorly understood. We show here that celastrol activates Hsf1 in Saccharomyces cerevisiae at a similar effective concen-
tration seen in mammalian cells. Transcriptional profiling revealed that celastrol treatment induces a battery of oxidant
defense genes in addition to heat shock genes. Celastrol activated the yeast Yap1 oxidant defense transcription factor via
the carboxy-terminal redox center that responds to electrophilic compounds. Antioxidant response genes were likewise
induced in mammalian cells, demonstrating that the activation of two major cell stress pathways by celastrol is conserved.
We report that celastrol’s biological effects, including inhibition of glucocorticoid receptor activity, can be blocked by the
addition of excess free thiol, suggesting a chemical mechanism for biological activity based on modification of key
reactive thiols by this natural product.
INTRODUCTION
The heat shock response (HSR) is an ancient and highly
conserved cytoprotective mechanism. Production of heat
shock proteins, including protein chaperones, is essential for
the folding, repair, or triage of damaged proteins; thus, it
serves to promote cellular viability under conditions that
would otherwise induce apoptosis (McMillan et al., 1998;
Christians et al., 2002). There is significant interest in the
discovery and development of small molecules that modu-
late the HSR and parallel stress response pathways for ther-
apeutic purposes (Morimoto and Santoro, 1998; Westerheide
and Morimoto, 2005; Corson and Crews, 2007). The HSR is
governed by the stress-inducible heat shock transcription
factor HSF1, which plays a key regulatory role in response to
environmental stress, development, and many pathophysi-
ological conditions, including cancer, ischemia-reperfusion
injury, diabetes, and aging (Morimoto and Santoro, 1998;
Morano and Thiele, 1999a).
Significant progress has been made in identifying HSF1-
modulating compounds such as triptolide and quercetin, in-
hibitors of HSF1, and activators such as the protein synthesis
inhibitor puromycin, the proteasome inhibitor MG132, the
nonsteroidal anti-inflammatory drugs salicylate and indometh-
acin, and the heat shock protein (Hsp)90 inhibitors radicicol
and geldanamycin (Hightower, 1980; Jurivich et al., 1992; Lee et
al., 1995; Nagai et al., 1995; Bagatell et al., 2000; Holmberg et al.,
2000; Westerheide et al., 2006). A large-scale screen for novel
pharmacologically active compounds that may be beneficial in
treating the neurological manifestations of Huntington’s dis-
ease and amyotrophic lateral sclerosis (ALS) identified the
natural product celastrol, a triterpenoid compound isolated
from the plant family Celastraceae (Abbott, 2002; Heem-
skerk et al., 2002). Root bark extracts from these plants are
commonly used in traditional Chinese medicine for their
anti-inflammatory properties, consistent with the recent
identification of celastrol as an effective inhibitor of nuclear
factor-B (Corson and Crews, 2007; Sethi et al., 2007). In
addition, celastrol reduces the neurotoxicity associated with
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1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)- and
3-nitropropionic acid-induced neurological degeneration in
mice (Cleren et al., 2005). Some of these anti-neurodegenera-
tive properties are likely attributable to activation of HSF1,
because celastrol induces HSF1 DNA binding and hyper-
phosphorylation to promote heat shock gene expression and
inhibits the function of the HSF1-repressor Hsp90 (Wester-
heide et al., 2004; Hieronymus et al., 2006). The chemical
mechanism(s) by which celastrol produces these numerous
physiological effects remains unknown.
Here, we report that celastrol activates Hsf1 in the yeast
Saccharomyces cerevisiae with characteristics closely mirroring
heat shock, including Hsf1 hyperphosphorylation, produc-
tion of HSPs, and induction of tolerance to a lethal heat
shock. Through genome-wide transcriptional profiling, we
show that celastrol concomitantly elicits a previously unap-
preciated oxidant defense response in yeast. Consistently,
celastrol treatment of RKO human colorectal carcinoma cells
induces antioxidant genes in parallel with heat shock tar-
gets. The influence of celastrol on multiple cellular pro-
cesses, including antioxidant response activation, heat shock
response activation, and inhibition of glucocorticoid recep-
tor maturation, is prevented by incubation with free thiols.
Together, these findings indicate that celastrol simulta-
neously activates multiple stress pathways that ultimately
impact cellular survival, and they highlight a potential
mechanism through which celastrol carries out its intracel-
lular effects via reacting with key thiols in proteins.
MATERIALS AND METHODS
Yeast Strains and Plasmids
Yeast strains used in this study were of the W303 (MATa ade2-1 trp1 can1-100
leu2-3112 his3-11,15 ura3) and BY4741 (MATa ura30 leu20 his31 met150)
strain backgrounds. The YAP1-TAP (tandem affinity purification tag) strain
and the gpx3::kanMX4 deletion strain (gpx3) were purchased from Open
Biosystems (Huntsville, AL), and they are otherwise isogenic with BY4741.
W303 HSF1-TAP was constructed through polymerase chain reaction (PCR)
amplification of the TAP tag sequence and selectable TRP marker from a
previously described plasmid construct (Puig et al., 1998). The resulting PCR
product was transformed into W303 cells and Trp colonies screened by
immunoblot for integration of the TAP-tag at the correct locus. The ability of
the HSF1-TAP allele to confer normal levels of heat shock resistance was used
as a diagnostic to confirm functionality of expressed Hsf1-TAP (data not
shown). The HSE-lacZ reporter plasmid (HSE-lacZ) and the yeast AP-1 (Yap1)
reporter pCEP12 (ARE-lacZ) have been described previously (Harshman et
al., 1988; Santoro et al., 1998). Yeast were grown either in nonselective condi-
tions in rich YPD (0.2% Bacto-peptone, 0.1% yeast extract, and 2% glucose) or
synthetic complete (SC) media. To maintain the solubility of celastrol, exper-
iments were performed as indicated with minimal media supplemented with
50 mM Tris-HCl, pH 7.5. Celastrol was dissolved as a 10 mM stock in
dimethyl sulfoxide (DMSO). Unless otherwise indicated, experiments were
performed with strains grown to logarithmic phase at 30°C. Dithiothreitol
(DTT) inactivation of celastrol was achieved by premixing the two chemicals
for 5 min before addition to cells. Plasmids p413GPD-rGR and pYRP-GRElacZ
(URA3) were used as described to determine Hsp90 chaperoning of heterolo-
gously expressed rat glucocorticoid receptor (Morano et al., 1999).
Mammalian Cell Culture, RNA Isolation, and Reverse
Transcription (RT)-PCR
RKO human colorectal carcinoma cells were grown in DMEM supplemented
with 10% fetal bovine serum and antibiotics. Cells were treated at 60–80%
confluence with varying concentrations of celastrol for 6 h. Total RNA was
isolated from cells using an RNeasy extraction kit (QIAGEN, Valencia, CA)
with on-column DNase I treatment according to the manufacturer’s direc-
tions. RNA (1.0 g) was reverse transcribed using the iScript cDNA synthesis
kit (Bio-Rad, Hercules, CA). Primers for RT-PCR have been reported previ-
ously (West and Marnett, 2005). PCR products were amplified with Taq
polymerase (Promega, Madison, WI) by using standard cycling conditions.
Reporter Assays
Cells harboring the lacZ transcriptional reporter fusions were harvested by
centrifugation and resuspended in selective media supplemented with 50 mM
Tris-HCl, pH 7.5. Cells were treated with 20 M celastrol or DMSO for 1 h at
30°C with continuous shaking and harvested by centrifugation. Cell pellets
frozen immediately in dry ice. -Galactosidase activity was determined as
described previously (Morano et al., 1999). Heat shock experiments using a
-galactosidase reporter were done at 37°C because 39°C was found to
diminish enzyme activity. Reporter assays for constructs containing individ-
ual transcription factor binding sites were performed as described previously
using RKO cells (West and Marnett, 2005). Luciferase reporter assays using
the stable HeLa-hsp70.1pr-luc cell line were performed as described previ-
ously (Westerheide et al., 2004).
Protein Analysis
Protein extracts were prepared using an alkaline lysis procedure as described
previously (Ooi et al., 1996). To analyze formation of the transient Yap1–
glutathione peroxidase 3 (Gpx3) complex, cells were immediately precipitated
with ice-cold 20% trichloroacetic acid after treatment. Cell extracts were
prepared by glass-bead lysis in nonreducing sample buffer and left untreated
or reduced with 10 mM DTT before SDS-polyacrylamide gel electrophoresis
(PAGE). Immunoblotting procedures were performed as described previ-
ously (Morano and Thiele, 1999b). Polyclonal antisera that recognizes both
Ssa3 and Ssa4 was a kind gift from E. Craig (University of Wisconsin,
Madison, WI). Antibodies against phosphoglycerate kinase (PGK) and TAP
tag (protein A epitope) were obtained from Invitrogen (Carlsbad, CA) and
Sigma-Aldrich (St. Louis, MO), respectively.
Heat Shock Sensitivity Assay
To assay celastrol-induced thermotolerance, BY4741 cells were resuspended
in SC media supplemented with 50 mM Tris-HCl, pH 7.5, and subsequently
treated with no reagent, 20 M celastrol, or DMSO for 1 h at 30°C. After the
treatment period, cells were diluted to an OD600 of 0.1 in sterile 0.2-ml PCR
tubes in 100 l. The diluted cells were heat shocked at 47°C in a thermocycler
for 0, 5, 10, 15, and 20 min. The aliquots were spotted in equal volume on solid
SC medium and incubated for 2 d at 30°C.
Transcriptional Profiling
Genome-wide transcriptional profiling was performed with logarithmic
BY4741 cells harboring the HSE-lacZ reporter. The reporter plasmid was
included in this experiment as a means to ensure adequate celastrol- and heat
shock-mediated induction. Cells used for the heat shock experiment were
divided into two equal volumes and either shifted to 39°C for 30 min or left
at 30°C for the duration of the heat shock. Cells used for the celastrol/DMSO
experiment were harvested by centrifugation and resuspended in minimal
media supplemented with 50 mM Tris-HCl, pH 7.5. Cells were treated with 10
M celastrol or an equal volume of DMSO and incubated for 1 h at 30°C. After
heat shock and celastrol treatment, cells were harvested by centrifugation,
and total RNA was isolated using an acid phenol-glass bead extraction
procedure (Santoro, et al., 1998). All RNA-labeling and DNA microarray
manipulations were performed by the University of Texas Southwestern
Medical Center at Dallas-Microarray Core Facility (http://microarray.
swmed.edu). The array consisted of duplicate sets of 6219 yeast genes printed
on glass slides, and hybridization values were obtained for each spot by using
GenePix software. The mean intensity for each gene was obtained in duplicate
from each of the replicated experiments, and a compound mean of signal
intensity was calculated from four independent spots. The compound mean
induction ratios are represented in Figure 2 after log2 transformation. Genes
shown in Table 1 are representative members of distinct gene groupings
whose transcript levels were induced twofold or greater in response to either
heat shock or celastrol treatment. The median induction ratios for the de-
scribed gene families were calculated in response to heat shock or celastrol
treatment, and a list of specific genes with respective individual changes in
gene expression is provided in Supplemental Table 1. Primary data sets are
accessible through the Gene Expression Omnibus (http://www.ncbi.nlm.
nih.gov/geo; accession no. GSE5608).
Yap1 Subcellular Localization
To assess the role of the Yap1 carboxy-terminal redox center in celastrol
activation, a previously generated synthetic construct that includes a simian
virus 40 (SV40) nuclear localization sequence and green fluorescent protein
(GFP) fused to the Yap1 redox regulatory domain was used (Yap1-RDGFP,
kindly provided by M. Wood, University of California, Davis) (Wood et al.,
2004). To examine involvement of Cys residues in Yap1 nuclear accumulation,
site-directed mutagenesis was performed using the QuikChange protocol
(Stratagene, La Jolla, CA) to make the following replacements: C598A, C620A,
and C629T. To obtain the C598,620A;C629T triple mutant, multiple rounds of
site-directed mutagenesis were performed. All plasmids were sequenced to
confirm mutagenesis. Plasmids were transformed into BY4741 and grown on
uracil-deficient media. Experiments were conducted on cells in log phase that
were resuspended in uracil-deficient liquid medium buffered with 50 mM
Tris, pH 7.4. Incubations were carried out for 5 min with 300 M H2O2 or 20
min for 10 M celastrol and 0.1% DMSO. Cells were imaged using an
Axiovert microscope (Carl Zeiss, Oberkochen, Germany).
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RESULTS
Celastrol Activates Hsf1 in Yeast and Confers Tolerance
to Thermal Stress
To understand the general mechanisms of cytoprotection
afforded by celastrol, we addressed whether the heat shock
response controlled by Hsf1 in S. cerevisiae is responsive to
celastrol treatment. Yeast Hsf1, like mammalian HSF1, spe-
cifically recognizes multimeric “nGAAn” repeat sequences
termed heat shock elements (HSEs) in promoters of target
genes (Sorger and Pelham, 1987). The wild-type yeast strain
BY4741 carrying an Hsf1-responsive HSE-lacZ reporter was
treated with concentrations of celastrol ranging from 0 to 40
M for a 1-h time period, and a dose-response curve was
generated based on the resulting activity of the reporter
construct (Figure 1A). The EC50 obtained from this assay
was 7.5 M, similar to the EC50 of 3.0 M observed in
mammalian cells (Westerheide et al., 2004). A reporter fusion
construct bearing multiple mutations in the HSE was not
induced by celastrol treatment, confirming that reporter ac-
tivation required a functional HSE (data not shown) (San-
toro et al., 1998). Induction of the HSE-lacZ reporter by 20
M celastrol was 40% of the level achieved by a standard
heat shock (30 min at 37°C), suggesting that celastrol is less
potent than heat shock for reporter activation with these
experimental conditions (Figure 1B).
Celastrol stimulates mammalian HSF1 DNA binding and
hyperphosphorylation in mammalian cells, events required
for activation of the heat shock response (Westerheide et al.,
2004). Both of these events occur with kinetics similar to heat
shock. Because yeast Hsf1 is constitutively bound to many
HSE-containing promoters in the absence of stress, we chose
to examine whether celastrol-mediated activation of Hsf1
produced changes in phosphorylation status similar to that
observed in response to heat shock (Sorger and Pelham,
1988). To test this, a wild-type strain (W303) containing a
genomic-TAP tagged allele of HSF1 was constructed to al-
low visualization of the altered mobility induced by phos-
phorylation. Hsf1-TAP cells were exposed to heat shock
(HS), celastrol, or DMSO treatment, and cells were harvested
before treatment, 15 min after treatment, and at the comple-
tion of the 1-h time course. Hsf1-TAP mobility was exam-
ined by immunoblot analysis. As shown in Figure 1C, celas-
trol induced the formation of a hyperphosphorylated form
of Hsf1-TAP within 15 min that is comparable with heat
shock (Sorger and Pelham, 1988; Liu and Thiele, 1996).
Treatment with DMSO alone did not result in a detectable
change in phosphorylation status. Restoration of basal phos-
phorylation levels was observed within 1 h in response to
both treatments, suggesting that heat shock and celastrol
exhibit similar features of attenuation.
The transcriptional activation of Hsf1-regulated genes in
response to heat shock results in increased levels of protein
chaperones essential for maintaining cellular viability dur-
ing exposure to elevated temperature. Yeast cells exposed to
a short period of sublethal elevated temperature (37°C) be-
fore exposure to lethal heat shock temperatures (42°C) are
more thermotolerant than untreated cells based in large part
on the action of Hsf1 (Nieto-Sotelo et al., 1990; Sorger, 1990).
We therefore assessed levels of two prominent heat shock-
inducible cytosolic Hsp70 chaperones encoded by the SSA3
and SSA4 genes (Boorstein and Craig, 1990). Wild-type cells
were untreated or exposed to heat shock, DMSO, or celastrol
treatment for 1 h, and protein extracts were analyzed by
immunoblot. As shown in Figure 1D, Ssa3/4 levels were low
under control conditions and induced by celastrol, albeit to
a lesser extent than heat shock (i.e., celastrol-induced levels
of Ssa3/4 were 65% of heat shock-induced levels as deter-
mined by densitometry). Because celastrol treatment in-
duced HSP expression in yeast, we reasoned that treatment
before lethal heat shock would significantly increase resis-
Table 1. Comparison of heat shock and celastrol-induced gene expression
Gene familya
Median induction ratiob
Heat shock (1.0) Celastrol (0.9)
Xenobiotic metabolism and clearance
Glutathione metabolic enzymes 2.2 5.7
ECM4, GLO1, GLO4, GLR1, GSH1, GTT2, YJL068C
Aryl-alcohol dehydrogenases 1.0 5.6
AAD3, AAD4, AAD6, AAD14, AAD15, AAD16
Other putative xenobiotic oxidoreductases 1.9 9.1
ADH5, ADH6, ALD4, ALD6, BDH2, FRE7, GRE2, GOR1, OYE2, OYE3, YDL124W,
YGL157W, YHB1, YML131S, YNL134C, YPR1, ZTA1
Export pumps 1.4 5.8
ATR1, FLR1, PDR5, PDR10, PDR15, PDR16, SNQ2, YCF1, YOR1
Protein folding, processing, and turnover
Chaperones and co-chaperones 6.2 4.9
CPR1, CPR6, HSP26, HSP31, HSC82, HSP82, HSP104, PDI1, PHB1, PHB2, SBA1,
SGT1, SSA1, SSA2, SSA4, SSE1
Protein reductants 1.2 3.7
AHP1, MXR1, TRX2
Regulators of protein turnover/proteasome subunits 2.0 3.1
BLM10, CDC48, DDI1, DSK2, ECM29, LAP4, NPL4, OUT1, PIM1, PRD1, PRE2, PRE3,
PRE4, PRE5, PRE6, PRE7, PRE10, PUP1, PUP2, PUP3, RPN1, RPN2, RPN3, RPN5,
RPN6, RPN7, RPN8, RPN9, RPN11, RPN12, RPN13, RPT1, RPT3, RPT5, RPT6,
SCL1, SHP1, UBA1, UBC5, UBI4, UBP6, UBX5, UFD1, UMP1, YME1
a Genes selected based on induction ratio 2.0.
b Global induction medians shown for each treatment in parentheses.
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tance to thermal stress. To test this hypothesis, wild-type
cells (BY4741) were left untreated, treated with DMSO, or
treated with celastrol for 1 h at 30°C and subsequently
exposed to a 47°C heat shock for 0, 5, 10, 15, or 20 min.
Equivalent cell numbers from each culture were spotted
onto solid media, and they were subsequently assayed for
viability after growth at 30°C for 2 d (Figure 1E). Although
cells receiving no treatment or DMSO exhibited a significant
reduction in viability (at least 10-fold by colony formation)
at the 15-min time period, celastrol treatment before heat
shock resulted in sustained viability after incubation at 47°C
for 20 min. Together, these data indicate that yeast Hsf1, like
mammalian HSF1, is activated by celastrol to increase stress
resistance and suggest a conserved mechanism of celastrol-
mediated activation among diverse eukaryotes.
Celastrol Induces Both Heat Shock- and
Oxidant-responsive Gene Expression
Our results indicate that celastrol modulates Hsf1 activity in
a manner similar to heat shock. We next sought to identify
other responses regulated by celastrol to understand more
fully its cytoprotective properties. We addressed this by
comparing global transcriptional profiles of yeast cells ex-
posed to heat shock or celastrol. Whole genome transcript
analysis was performed using RNA isolated from wild-type
cells left untreated, exposed to heat shock, DMSO, or 10 M
celastrol. Transcript induction ratios for each gene were
averaged over replicate experiments and plotted as fold
induction with celastrol versus fold induction with heat
shock. Strongly induced genes are indicated in Figure 2, and
a more comprehensive list of gene families induced by celas-
trol is in Table 1. The induced genes fall into two major
groupings: 1) xenobiotic metabolism/clearance and 2) pro-
tein folding, processing, and turnover. Celastrol and heat
shock commonly induce a subset of genes that primarily
encode protein chaperones. As calculated in Table 1, a set of
sixteen known Hsf1 targets exhibited a median induction
ratio of 6.2-fold by heat shock, whereas celastrol treatment
resulted in a 4.9-fold increase (Hahn et al., 2004). We also
noted a significant increase in levels of genes encoding pro-
teasome components in the array, consistent with a previous
report (Hahn et al., 2006). In addition, celastrol increased
levels of genes with cellular roles in xenobiotic metabolism
(Figure 2 and Table 1). Many of these genes, including those
encoding protein reductants such as TRX2, glutathione-met-
abolic enzymes such as GSH1, aryl-alcohol dehydrogenases
(AADs), and multidrug resistance pumps, are not known
targets of Hsf1, but they are targets of the transcription
factor Yap1 (Jamieson et al., 1994; Gasch et al., 2000; Gasch
and Werner-Washburne, 2002).
Figure 1. Celastrol activates yeast Hsf1 and induces thermotolerance.
(A) Wild-type (BY4741) cells containing an HSE-lacZ reporter were
treated with concentrations of celastrol ranging from 0 to 40M for 1 h,
and -galactosidase activity was determined as described in Materials
and Methods. (B) The same cells as in A were grown at control temper-
ature (30°C,), heat shocked at 37°C for 1 h (HS), or exposed to DMSO
or celastrol (cel, 20 M), and -galactosidase activities were deter-
mined. (C) W303 HSF1-TAP cells exposed to normal growth temper-
atures (30°C), heat shock (39°C), DMSO, or 10 M celastrol were
harvested at the indicated time points. Protein extracts were analyzed
by SDS-PAGE and immunoblot analysis and Hsf1-TAP detected using
antibodies directed against the protein A epitope. Extract prepared
from W303 cells grown under normal growth conditions was used as
a negative control (). (D) Wild-type (BY4741) cells were exposed to
30°C, 39°C, DMSO, or 20M celastrol for 1 h, and protein extracts were
analyzed by SDS-PAGE and immunoblot. Ssa3/4 levels were detected
using polyclonal antibodies that detect both heat shock-inducible iso-
forms of the yeast Hsp70. PGK levels were determined as a loading
control. (E) Wild-type (BY4741) cells were treated for 1 h with either no
reagent, DMSO, or 10 M celastrol for 1 h before heat shock at 47°C for
the indicated times as described in Materials and Methods. Cells were
spotted in equal volume on SC medium, and viability was assayed
after growth at 30°C for 2 d.
Figure 2. Celastrol simultaneously activates transcription of heat
shock and antioxidant genes in yeast. Parallel cultures of wild-type
yeast were left untreated (DMSO) or treated with 10 M celastrol for
1 h, or they were subjected to a 39°C heat shock for 30 min. RNA
was isolated and processed for transcriptional profiling by DNA
microarray as described in Materials and Methods. Mean induction
ratios for each treatment were calculated for each gene, transformed
to log2 and plotted. Selected genes exhibiting significant induction
in both treatments are labeled.
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Celastrol Activates the Yap1 Transcription Factor through
Its Carboxy-terminal Domain
Because our array studies suggested that celastrol activates
Yap1 and the mechanism of activation of this transcription
factor is known, we used Yap1 as a model to further dissect
celastrol’s biological effects. Yap1 contains two cysteine-rich
domains clustered into two distinct redox centers (n-CRD
and c-CRD; Figure 3A), and it is responsive to a variety of
thiol-modifying molecules, including oxidants and electro-
philes (Coleman et al., 1999; Kuge et al., 2001; Delaunay et al.,
2002; Azevedo et al., 2003; Maeta et al., 2004). Specifically,
Yap1 activation by H2O2 requires the thiol peroxidase
Gpx3/Orp1 (Delaunay et al., 2002), and it involves formation
of two disulfide bonds between cysteines 303–598 and 310–
629 (Delaunay et al., 2000; Wood et al., 2003; Okazaki et al.,
2007). Therefore, we tested whether Yap1 was activated by
celastrol treatment and whether this activation required
Gpx3 by using a transcriptional lacZ reporter containing a
Yap1 response element (Harshman et al., 1988). Wild-type
(BY4741) and gpx3 cells containing the reporter (ARE-lacZ)
were left untreated or treated for 1 h with DMSO, 300 M
H2O2, or 10 M celastrol, and they were subsequently as-
sayed for -galactosidase activity. As shown in Figure 3B,
celastrol treatment resulted in approximately six-fold acti-
vation of the reporter, and this induction occurred indepen-
dently of Gpx3. In contrast, H2O2 induced the reporter in
wild-type cells, whereas no induction was observed in the
gpx3 mutant.
The transient Yap1-Gpx3 complex induced by H2O2 can be
detected by nonreducing SDS-PAGE (Delaunay et al., 2002).
Based on the stimulation of Yap1 reporter activity by celastrol
in the absence of Gpx3, we predicted that celastrol treatment
would not induce formation of intermolecular disulfides. Cells
expressing an integrated TAP-tagged allele of Yap1 were
treated with DMSO, 300 M H2O2 or 10 M celastrol for 10
min, followed by protein extraction in nonreducing sample
buffer. H2O2 induced formation of a slower-migrating species
that disappeared upon disulfide reduction, as previously
shown (Figure 3C). In contrast, treatment with celastrol or
DMSO did not induce formation of the Yap1–Gpx3 complex.
These data suggest that celastrol, unlike H2O2, exhibits the
profile of other thiol-reactive compounds that modify the car-
boxy-terminal Gpx3-independent redox center without forma-
tion of interdomain disulfide bonds.
On modification of cysteine residues within the CRDs of
Yap1, nuclear export is impaired, causing its nuclear retention
to facilitate target gene expression (Kuge et al., 1998; Yan et al.,
1998). We used a previously generated minimal Yap1 regula-
tory domain construct bearing the n-CRD, c-CRD, GFP, and
the SV40 nuclear localization sequence (Yap1-RDGFP) to mon-
itor changes in Yap1 subcellular localization in response to
H2O2 and celastrol (Wood et al., 2004). On treatment of yeast
expressing the wild-type fusion protein, nuclear accumulation
was observed for both celastrol and H2O2, as shown in Figure
3D. However, upon mutation of C598 to alanine and C629 to
threonine, nuclear accumulation was observed only for celas-
trol, consistent with the inability to form either of the two-
domain disulfides. In contrast, mutation of C620 in Yap1 al-
lowed H2O2-mediated nuclear accumulation but substantially
reduced the amount of nuclear accumulation observed with
celastrol. The Yap1 reporter containing all three carboxy-termi-
nal cysteine mutations (AAT) failed to respond to either celas-
trol or H2O2. These results, when considered with the observed
independence of Gpx3, indicate that celastrol induces Yap1
through a disulfide-independent mechanism, perhaps through
direct alkylation of one or more cysteine residues within and
adjacent to the nuclear export sequence located in the c-CRD.
Induction of Multiple Cytoprotective Genes by Celastrol
in Mammalian Cells
Our microarray results in yeast led us to hypothesize that
celastrol induces multiple genes involved in providing protec-
Figure 3. Celastrol activates the yeast oxidant-
responsive transcription factor Yap1 through the
carboxy-terminal domain. (A) Schematic of Yap1
cysteine residues involved in oxidation and alky-
lation. (B) Wild-type (BY4741) and gpx3 cells con-
taining the Yap1 reporter (pCEP12) were treated
with either no reagent, 300 M H2O2, DMSO, or
10 M celastrol. Harvested cells were subse-
quently assayed for -galactosidase activity as de-
scribed previously. (C) Cells expressing a TAP-
tagged allele of YAP1 from the endogenous
genomic locus were grown to logarithmic phase
and treated with DMSO, 300 M H2O2, or 10 M
celastrol for 10 min, followed by trichloroacetic
acid precipitation. Cell extracts were prepared by
glass-bead lysis in nonreducing sample buffer and
either left untreated (DTT) or reduced with 10
mM DTT (DTT) before SDS-PAGE. Yap1 migra-
tion was detected using anti-protein A antibody.
The locations of the Yap1-TAP fusion and the
DTT-sensitive Yap1-TAPGpx3 heterodimer are
indicated. (D) Cells expressing either wild-type or
mutant GFP-Yap1 regulatory domain fusion pro-
teins were treated with DMSO, 300 M H2O2, or
10 M celastrol to monitor GFP subcellular local-
ization as described in Materials and Methods. Car-
toon illustrates diffuse Yap1-GFP fluorescence
before modification of the c-CRD (by either path-
way), and nuclear localization after treatment. The
yeast vacuole is indicated by a dark gray circle in
the cartoon. Results are representative of three
independent experiments.
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tion against oxidative injury, in addition to activating a potent
heat shock response. To determine whether celastrol simulta-
neously activates additional mammalian cytoprotective re-
sponses similar to that seen in S. cerevisiae, we examined a
number of heat shock response- and antioxidant response-
regulated transcripts. The latter response is controlled by the
action of two transcription factors, NF-E2-related factor-2
(Nrf2) and activating transcription factor 4 (Atf4) (He et al.,
2001; Harding et al., 2003; Nguyen et al., 2003). Human colo-
rectal carcinoma (RKO) cells were exposed to increasing doses
of celastrol for 6 h to monitor changes in HSF1, Nrf2, and/or
Atf4 targets. A dose-dependent induction was observed in the
heat shock genes HspA6 and DnaJA4, heme oxygenase-1
(HO1), the regulatory subunit of glutamate-cysteine ligase
(GCLM), a cystine transporter subunit (xCT), and the growth
arrest- and DNA damage-inducible gene 34 (Gadd34) (Figure
4A) (Fornace et al., 1989; Leung et al., 1990; He et al., 2001; Sasaki
et al., 2002; Levonen et al., 2004).
To determine whether HSF1, Nrf2, and Atf4 were acti-
vated by celastrol, we used a previously generated reporter
library consisting of binding sites for these transcription
factors (i.e., HSE, antioxidant response element [ARE], and
nutrient-sensing response element [NSRE], respectively)
cloned upstream of a minimal promoter to regulate lucif-
erase expression (West and Marnett, 2005). On treatment of
RKO cells transiently transfected with these plasmids, we
found that celastrol induced reporter expression above con-
trol vector (pGL3-promoter) for each transcription factor
(Figure 4B). Together, these results indicate that celastrol
induces both oxidant defense and heat shock responses in
mammalian cells as in yeast, and they suggest that celastrol
promotes simultaneous activation of HSF1, Nrf2, and Atf4.
Biological Effects of Celastrol Are Inhibited by Free Thiols
Our results suggest that celastrol possesses the signaling
profile of a thiol-modifying molecule (Gasch et al., 2000;
Causton et al., 2001). If celastrol acts intracellularly via a
thiol-reactive mechanism, then excess free thiols would pre-
vent target modification and thereby decrease its pharma-
cological potency. We therefore treated yeast cells contain-
ing either the HSE-lacZ (Hsf1) or ARE-lacZ (Yap1) reporters
with 10 M celastrol in the presence or absence of the
reducing agent DTT at 50 M. The results reveal that DTT
significantly blocked celastrol-mediated activation of both
responses in our assays, whereas DTT alone had no effect
(Figure 5A). We extended these results by investigating the
ability of DTT to prevent celastrol-mediated activation of
HSF in HeLa cells stably transfected with a hsp70.1-lucif-
erase reporter (Westerheide et al., 2004). This cell line was
treated with 5 M celastrol that was incubated with a range
of DTT concentrations between 0 and 250 M. We observed
a dose-dependent inhibition of luciferase induction with
increasing DTT concentration, with 50% inhibition at ap-
proximately 10-fold excess of DTT (Figure 5B). Likewise,
induction of heat shock response- and antioxidant response-
inducible transcripts in RKO cells was decreased upon in-
cubation of celastrol with 250 M DTT (Figure 5C). These
data indicate that DTT blocks activation of two distinct
stress pathways by celastrol in both mammalian and yeast
cells, and they are consistent with a model wherein celastrol
interacts with reactive thiols to regulate both the heat shock
and antioxidant responses.
Recently, celastrol was identified for its ability to inhibit
nuclear hormone receptor maturation and function, a pro-
cess that requires the molecular chaperone Hsp90 (Hierony-
mus et al., 2006). We tested whether celastrol acts as an
inhibitor of nuclear hormone receptor transactivation by
using an assay system that consists of the rat glucocorticoid
receptor (GR) coupled with a plasmid bearing a glucocorti-
coid response element driving -galactosidase (GRE-lacZ)
(Picard, 1990). Treatment of yeast containing the plasmids
with deoxycorticosterone (DOC, a synthetic activator of GR)
for 1.5 h resulted in a six-fold induction in cells treated with
DMSO only (Figure 5D). In contrast, pretreatment for 1 h
with 10 M celastrol before DOC exposure blocked hor-
mone-dependent induction. This effect was not observed
when cells were treated with celastrol and a fivefold excess
of DTT. Together, these findings suggest an explanation for
the mode of action for celastrol in yeast and human cells
based on modification of key reactive thiols.
DISCUSSION
In this study, we sought to elucidate the mechanism(s)
through which the triterpenoid celastrol affords cytoprotec-
tion in response to stress. The findings that celastrol acti-
vates Hsf1, promotes molecular chaperone expression, and
increases viability upon lethal heat shock in yeast and mam-
malian cells suggest a highly conserved biochemical mech-
anism (Figure 1). Moreover, celastrol potently induces genes
involved in xenobiotic detoxification in yeast and mamma-
lian cells as part of the antioxidant response (Figures 2 and
4 and Table 1). This response in S. cerevisiae is regulated by
the transcription factor Yap1, a protein that undergoes nu-
Figure 4. Celastrol activates the mammalian anti-
oxidant response. (A) RNA was isolated from RKO
cells treated with the indicated doses of celastrol or
DMSO vehicle and reverse-transcribed as described
in Materials and Methods. PCR reactions were per-
formed on cDNAs for the indicated transcripts. 18S
RNA levels were assayed to determine equal load-
ing. Similar results were obtained in three indepen-
dent experiments. (B) RKO cells were transfected
with luciferase constructs for 20–24 h. Cells were
treated with the indicated concentrations of celastrol
for 8 h, lysed, assayed for firefly luciferase activity,
and normalized for transfection efficiency with Re-
nilla luciferase activity. Results (mean  SD) are
from triplicate cell treatments and are representative
of two independent experiments.
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clear accumulation and promotes target gene expression
after modification of specific cysteine residues in its regula-
tory domain (Figure 3). Consistently, modulation of the
antioxidant response, the heat shock response, and nuclear
hormone receptor function, was prevented by incubation of
celastrol with free thiols (Figure 5), suggesting a thiol-reac-
tive mechanism for this compound.
A variety of oxidants and electrophiles are potent induc-
ers of the heat shock response and the antioxidant response
(Morimoto and Santoro, 1998; Dinkova-Kostova et al., 2005).
Although celastrol is not purported to be a direct protein
oxidant, two predicted electrophilic centers reside within the
A and B rings of celastrol (Figure 6), where nucleophilic
amino acid residues (e.g., cysteine) in multiple target pro-
teins may react to form covalent adducts (Huang et al., 1998;
Yang et al., 2006). Structural analogs of celastrol with altered
double bond arrangement in the A and B rings lack these
reactive centers, and they are pharmacologically less potent
as inhibitors of inflammatory signaling (He et al., 1998;
Huang et al., 1998). Additionally, incubation of celastrol with
excess thiols (e.g., DTT) results in its inactivation in multiple
biological assays (Figure 5) (Lee et al., 2006). Therefore, these
results suggest that the electrophilic character of the A and
B rings of celastrol is responsible for altering signaling re-
sponses in both yeast and mammalian cells by modifying
many proteins on cysteine residues.
The mechanism by which celastrol induces the heat shock
response in yeast and mammalian cells remains a matter of
investigation, and it may involve inactivation of several
protein complexes involved in protein folding and turnover,
specifically through targeting cysteine residues in one or
more molecular chaperones and the proteasome. Inactiva-
tion of either the molecular chaperone machinery or the
proteasome promotes Hsf1 activation and increases Hsp
levels (Westerheide and Morimoto, 2005). In support of this
reasoning, celastrol induces a gene expression profile similar
to that reported for Hsp90 inhibitors in a chemical genetic
Figure 5. Biological effects of celastrol are blocked
by free thiol. (A) The effects of DTT on celastrol-
mediated induction of Hsf1 and Yap1 in yeast were
assessed by treating BY4741 cells bearing the HSE-
lacZ plasmid or the ARE-lacZ plasmid (pCEP12)
with celastrol alone (10 M), celastrol (10 M) that
had been preincubated with DTT (50 M) for 5 min,
or the indicated controls for 1 h, followed by -ga-
lactosidase assay. Results shown are the mean with
SD from three independent experiments. (B) The
efficacy of DTT inhibition of celastrol activation of
mammalian HSF was tested in HeLa cells by using a
firefly luciferase reporter fused to a hsp70.1 promoter
fragment. Celastrol (5 M) was mixed with the in-
dicated concentrations of DTT for 30 min before cell
treatment for 8 h, followed by luciferase assay. (C)
Heat shock response- and antioxidant response-induc-
ible genes were tested for the effects of DTT on celas-
trol in RKO cells. Celastrol (3 M) was incubated with
250 M DTT for 1 h before cell treatment. RKO cells
were incubated under the indicated conditions for 6 h
before RNA isolation and transcript analysis. Results
are representative of two independent experiments.
(D) BY4741 cells transformed with the glucocorticoid
receptor assay system (p413GPD-rGR and pYRP-
GRElacZ) were treated as described in A, followed by
treatment with 10 M DOC or vehicle alone for 1.5 h.
-Galactosidase activity was determined as described
in Materials and Methods.
Figure 6. Model for celastrol-mediated cellular adaptation and cyto-
protection. The rings of celastrol are identified by italic capital letters
(A–E), and they are described in detail in Discussion. Celastrol treat-
ment is shown to activate both heat shock and antioxidant pathways,
resulting in increased expression of a number of cytoprotective genes.
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screen (Hieronymus et al., 2006) and functionally inactivates
GR, an Hsp90 client, in yeast (Figure 5D). These results
suggest that celastrol has a pronounced influence on Hsp90
chaperone activity, although the exact biochemical mecha-
nism of Hsp90 inhibition is unclear. Several proteomic stud-
ies have identified Hsp90 and other molecular chaperones
(e.g., Hsp70, peptidylprolyl isomerases) as targets of cys-
teine-modifying agents, and these molecules inactivate both
Hsp90 and Hsp70 in in vitro refolding assays (Carbone et al.,
2004, 2005). Collectively, these findings suggest that multi-
ple molecular chaperones may be inactivated by celastrol
and related molecules. In addition, celastrol promotes accu-
mulation of polyubiquitinated proteins and inhibits protea-
some function, specifically by inactivating its chymotrypsin-
like activity (Yang et al., 2006). It is possible that celastrol
promotes Hsf1 activation by modifying cysteine residues in
multiple proteins involved in protein folding and clearance.
To explore the regulation of oxidant defense genes by celas-
trol, we focused our efforts on Yap1 due to its direct regulation
by cysteine-modifying agents. On exposure to either oxidants
or electrophiles, Yap1 accumulates in the nucleus, where it
promotes the expression of multiple genes involved in xeno-
biotic detoxification and export, including TRX2, PDR5, SNQ2,
FLR1, YCF1, and ATR1 (Kuge and Jones, 1994; Wemmie et al.,
1994; Miyahara et al., 1996; Alarco et al., 1997; Coleman et al.,
1997; Kuge et al., 1997). All of these genes are induced strongly
by celastrol in our microarray experiments (Table 1). Oxidants
and electrophiles promote Yap1 nuclear retention and activity
through modifying cysteines within or in proximity to the
nuclear export sequence. With celastrol, we observed that Yap1
is activated in a GPX3-independent manner and that the C-
terminal cysteine residues required for nuclear accumulation
differ substantially from those involved in oxidation by H2O2
(Figure 3). Together, our results suggest that celastrol regulates
Yap1 through direct adduction of one or more cysteine resi-
dues within the carboxy-terminal domain, rather than through
oxidation.
In both yeast and mammalian cells, global gene expression
profiling experiments reveal that celastrol induces two key
transcriptional regulons (Figure 2) (Hieronymus et al., 2006).
These genes are regulated by various transcription factors,
including Hsf1 and Yap1 in S. cerevisiae and HSF1, Nrf2, and
Atf4 in mammalian cells. As a result, we suggest a model
wherein celastrol activates these transcription factors; pro-
motes expression of genes involved in detoxification and ex-
port of reactive species, protein folding, and protein turnover;
and affords protection against further environmental challenge
(Figure 6). Because many of these genes carry out fundamental
cytoprotective roles, induction of adaptive responses by celas-
trol and related molecules through modification of cysteines in
target proteins represents a promising area of therapeutic ex-
ploration to prevent or ameliorate the effects of diverse condi-
tions, including cardiovascular disease, cancer, and protein
aggregation disorders.
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